eISSN: 2450-4459
ISSN: 2450-3517
Lekarz POZ
Bieżący numer Archiwum Artykuły zaakceptowane O czasopiśmie Bazy indeksacyjne Prenumerata Kontakt Zasady publikacji prac
2/2018
vol. 4
 
Poleć ten artykuł:
Udostępnij:
więcej
 
 
streszczenie artykułu:
Artykuł przeglądowy

Współczesne zasady leczenia bólu w chorobach reumatycznych

Brygida Kwiatkowska

Data publikacji online: 2018/05/25
Pełna treść artykułu
Pobierz cytowanie
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
Ból jest bardzo częstym objawem większości chorób reumatycznych. Strategia leczenia bólu w tych chorobach powinna polegać na skutecznym leczeniu bólu ostrego i zapobieganiu jego przejściu w ból przewlekły. W zapalnych chorobach reumatycznych, np. w reumatoidalnym zapaleniu stawów, można uzyskać skuteczną eliminację bólu przewlekłego poprzez wczesne i właściwe zastosowanie tzw. leków modyfikujących przebieg choroby. W przypadku choroby zwyrodnieniowej czy bólów kręgosłupa o wieloczynnikowej etiologii stosuje się głównie leczenie objawowe, skupione przede wszystkim na bólu. Do najczęstszych leków stosowanych w leczeniu bólu należą niesteroidowe leki przeciwzapalne. Strategia leczenia przeciwbólowego powinna być dobrana indywidualnie dla każdego pacjenta. Należy wybierać leki, które mogą najskuteczniej opanować ból, jednocześnie powodując jak najmniej objawów niepożądanych. Przy doborze leków należy brać pod uwagę zarówno wiek pacjenta, jak i schorzenia współistniejące i preparaty stosowane w ich leczeniu.

Pain is a one of very common symptoms of most rheumatic diseases. A strategy for the treatment of pain in these diseases consist in the effective treatment of acute pain and prevention of its transition to chronic pain. In inflammatory rheumatic diseases, e.g. in rheumatoid arthritis, it is possible to achieve effective elimination of chronic pain through the early and proper use of the disease-modifying antirheumatic drugs. In the case of osteoarthritis or spinal pain with multifactorial etiology the symptomatic treatment is mainly used. The most commonly used in the pain treatment are non-steroidal anti-inflammatory drugs. The analgesic treatment strategy should be individually selected for each patient. In the selection of medication, both the age of the patient and the concomitant diseases and preparations used for their treatment should be taken into account.
słowa kluczowe:

paracetamol, NLPZ, opioidy, incydenty sercowo-naczyniowe, powikłania dotyczące przewodu pokarmowego

referencje:
Litwic A, Edwards M, Dennison E i wsp. Epidemiology and Burden of Otseoarthritis. Br Med Bull 2013; 105: 185-199.
Wong R, Davis AM, Badley E i wsp. Prevalence of Arthritis and Rheumatic Diseases around the World A Growing Burden and Implications for Health Care Needs. Models of Care in Arthritis, Bone & Joint Disease (MOCA), Toronto 2010; www.acreu.ca/moca
McQuay H, Moore RA (red.). Epidemiology of chronic pain. IASP Press, Seattle 2008.
Mills S, Torrance N, Smith BH. Identification and management of chronic pain in primary care: a review. Curr Psychiatry Rep 2016; 16: 22.
Phillips K, Clauw DJ. central pain mechanisms in rheumatic diseases: future directions. Arthritis Rheum 2013; 65: 291-302.
Whittle SL, Colebatch AN, Buchbinder R i wsp. Multinational evidence-based recommendations for pain management by pharmacotherapy in inflammatory arthritis: integrating systemic literature research and expert opinion of broad panel of rheumatologists in the 3e Initiative. Rheumatology 2012; 51: 1416-1425.
Graham GG, Scott KF. Mechanism of action of paracetamol. Am J Ther 2005; 12: 46-55.
Englbrecht M, Tarner IH, Van Der Heijde D i wsp. Measuring pain and efficacy of pain treatment in inflammatory arthritis: a systemic literature review. J Rheumatol 2012; 90: 3-10.
Sendlbeck M, Araujo EG, Schett G i wsp. Psychometric properties of three single-item pain skales in patients with rheumatoid arthritis seen during routine clinical care: a comparative perspective on construct validity, reproducibility and internal responsiveness. RMD Open 2015; 1: e000140.
Machado GC, Maher CG, Ferreira PH i wsp. Efficacy and safety of paracetamol for spinal pain and osteoarthritis: systematic review and meta-analysis of randomised placebo controlled trials. BMJ 2015; 350: h1225.
Fitzcharles MA, Lussier D, Shir Y. Management of chronic arthritis pain in the elderly. Drugs Aging 2010; 27: 471-490.
Fored CM, Ejerblad E, Lindblad P i wsp. Acetaminofen, aspirin and chronic renal failure. N Engl J Med 2001; 345: 1801-1808.
Guggenheimer J, Moore PA. The therapeutic applications of and risks associated with acetaminofen use: a review and update. J Am Dental Asoc 2011; 142: 38-44.
Rahme E, Pettitt D, LeLorier J. Determinants and Sequelae Associated With Utilization of Acetaminophen Versus Traditional Nonsteroidal Antiinflammatory Drugs in an Elderly Population. Arth Rheum 2002; 46: 3046-3054.
Bruyère O, Cooper C, Pelletier JP i wsp. A consensus statement on the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) algorithm for the management of knee osteoarthritis. From evidence-based medicine to the real-life setting. Sem Arthritis Rheum 2016; 45: S3-S11.
Caldeira D, Costa J, Barra M i wsp. How safe is acetaminophen use in patients treated with vitamin K antagonists? A systematic review and meta-analysis. Thromb Res 2015; 135: 58-61.
Tarner IH, Englbrecht M, Schneider M i wsp. The role of corticosteroids for pain relief in persistent pain of inflammatory arthritis: a systemic literature review. J Rheumatol 2012; 90: 17-20.
Hirsch G, Kitas G, Klocke R. Intra-articular corticosteroid injection in osteoarthritis of the knee and hip: factors predicting pain relief – a systematic review. Semin Arthritis Rheum 2013; 42: 451-473.
Jüni P, Hari R, Rutjes AW i wsp. Intra-articular corticosteroid for knee osteoarthritis. Cochrane Database Syst Rev 2015; 22: CD005328.
Heidi J, Kym H, Gordon JH. The clinical effectiveness of intra-articular corticosteroids for arthritis of the lower limb in juvenile idiopathic arthritis: a systematic review. Pediatr Rheumatol Online J 2014; 12: 23-34.
Gvozdenovic E, Dirven L, van den Broek M i wsp. Intra articular injection with corticosteroids in patients with recent onset rheumatoid arthritis: subanalyses from the best study. Clin Rheumatol 2014; 33: 263-267.
Beltrame A, Grangiè S, Guerra L. Clinical experience with eperisone in the treatment of acute low back pain. Minerva Med 2008; 99: 347-352.
Khan AF, Parveen K, Khan AS. Efficacy and tolerability of eperisone versus tizanidine in patients suffering from low back pain with muscle spasm. Int J Res Med Sci 2017; 5: 2694-2700.
Zhao YW, Sheng YS, Shu J i wsp. Efficacy and safety of duloxetine on osteoarthritis knee pain: a meta-analysis of randomized controlled trials. Pain Med 2015; 16: 1373-1385.
Moore RA, Cai N, Skljarevski V i wsp. Duloxetine use in chronic painful conditions – individual patient data responder analysis. Eur J Pain 2014; 18: 67-75.
Philips K, Clauw DJ. Central pain mechanisms in chronic pain states-maybe it is all their head. Best Pract Res Clin Rheumatol 2011; 25: 141-154.
Ferjan I, Lipnik-Štangelj M. Chronic pain treatment: the influence of tricyclic antidepressants on serotonin release and uptake in mast cells. Med Inflam 2013; ID 340473.
Hochberg MC, Altman RD, April KT i wsp. American College of Rheumatology 2012: Recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of hand, hip, and knee. Arthritis Care Res 2012; 64: 465-474.
Deal CL, Schnitzer TJ, Lipstein E i wsp. Treatment of arthritis with topical capsaicin: a double-blind trial. Clin Ther 1991; 13: 383-395.
Wiffen PJ, Derry S, Bell RF i wsp. Gabapentin for chronic neuropathic pain in adults. Cochrane Database Syst Rev 2017; 6: CD007938.
Solomon DH, Rassen JA, Glynn RJ i wsp. The comparative safety of analgesics in older adults with arthritis. Arch Intern Med 2010; 170: 1968-1976.
Furlan AD, Sandoval AJ, Mailis-Gagnon A i wsp. Opioids for chronic noncancer pain: a meta-analysis of effectiveness and side effects. CMAJ 2006; 174: 1589-1594.
Banta-Green CJ, Merrill JO, Doyle SR i wsp. Opioid use behaviors, mental health and pain – development of a typology of chronic pain patients. Drug Alcohol Depend 2009; 104: 34-42.
Fishbain DA, Cole B, Lewis J i wsp. What percentage of chronic nonmalignant pain patients exposed to chronic opioid analgesic therapy develop abuse/addiction and/or aberrant drug-related behaviors? A structured evidence-based review. Pain Med 2008; 9: 444-459.
Whittle SL, Bethan R, Husani E i wsp. Opioid therapy for treating rheumatoid arythritis pain. Cochrane Database Syst Rev 2011; 1: CD003113.
Solomon DH, Rassen JA, Glynn RJ i wsp. The comparative safety of analgesics in older adults with arthritis. Arch Intertn Med 2019; 170: 1968-1976.
Meine TJ, Roe MT, Chen AY i wsp. CRUSADE Investigators, association of intravenous morphine use and outcomes in acute coronary syndromes: results from the CRUSADE Quality Improvement Initiative. Am Heart J 2005; 149: 1043-1049.
Perrot S, Krause D, Crozes P, Naïm C. Efficacy and tolerability of paracetamol/tramadol (325 mg/37.5 mg) combination treatment compared with tramadol (50 mg) monotherapy in patients with subacute low back pain: a multicenter, randomized, double-blind, parallel-group, 10-day treatment study. Clinical Therapeutics 2006; 28: 1592-1606.
Wang R, Dasqupta A, Ward MM. Comparative efficacy of non-steroidal anti-inflammatory drugs in ankylosing spondylitis: a Bayesian network meta-analysis of clinical trials. Ann Rheum Dis 2016; 75: 1152-1160.
Costantino C, Marangio E, Coruzzi G. Mesotherapy versus Systemic Therapy in the Treatment of Acute Low Back Pain: A Randomized Trial. Evid Based Complement Alternat Med 2011; 2011. pii: 317183.
Mammucari M, Gatti A, Maggiori S i wsp. Role of mesotherapy in musculoskeletal pain: opinions from the italian society of mesotherapy. Evid Based Complement Alternat Med 2012; 2012: 436959.
Mammucari M, Maggiori E, Maggiori S i wsp. Low back pain in patients with systemic analgesic intolerance managed with mesotherapy: a case report. J Med Cas 2014; 5: 238-240.
Vonkeman H, van de Laar MA. Nonsteroidal anti-inflammatory drugs: adverse effects and their prevention. Semin Arthritis Rheum 2010; 39: 294-312.
Papatheodoridis GV, Sougioultzis S, Archimandritis AJ. Effects of Helicobacter pylori and nonsteroidakl anti-inflammtory drugs on peptic ulcer disease: a systemic review. Clin Gastroenterol Hepatol 2006; 4: 130.
Lanza PL, Chan FKL, Quigley EMM. Guidellnes for prevention of NSAD-related ulcer complication. Am J Gastroenterol 2009; 104: 728-738.
Sheth T, Pitchumoni CS, Das KM. Management of musculoskeletal manifestation in inflammatory bowel disease. Gastroenterol Res Pract 2015; ID 387891.
Wallace JL. Mechanisms, prevention and clinical implication of nonsteroidal anti-inflammatory drug entheropathy. World J Gastroenterol 2013; 19: 1861-1876.
Ribaldone DG, Fagoonee S, Astegiano M i wsp. Coxib safety in patients with inflammatory bowel diseases: a meta-analysis. Pain Physician 2015; 18: 599-607.
Xiao X, Nakatsu G, Jin Y i wsp. Gut microbioma mediates protection against enteropathy induced by indomethacin. Sci Rep 2017; 9: 40317.
Montalto M, Gallo A, Gasbarrini A i wsp. NSAID enteropathy: could probiotics prevent it? J Gastroenterol 2013; 48: 689-697.
Bally M, Dendukuri N, Rich B i wsp. Risk of acute myocardial infarction with NSAIDs in real world use: bayesian meta-analysis of individual patient data. BMJ 2017; 357: j1909.
Friedewald VE, Bennet JS, CVhristo JP i wsp. AJC Editor’s consensus: Selective and nonselective anti-inflammtory drugs and cardiovascular risk. Am J Cardiol 2010; 106: 873-884.
Fored CM, Ejerbald E, Lindblad P i wsp. Acetaminophen, aspirin and chronić renal failure: a nationwide cas-control study in Sweden. N Engl J Med 2001; 345: 1801-1808.
Schneider V, Levesque LE, Zhang B i wsp. Association of selective and conventional nonsteroidal antiinflammatory drugs with acute renal failure: a population-based, nested case-control analysis. Am J Epidemiol 2006; 164: 881-889.
Whide WB. Defining the problem of treating the patient with hypertension and arthritis pain. Am J Med 2009; 122 (5 Suppl): 53-59.
Brater DC. Drug-drug and drug-disease interaction with nonsteroidal anti-inflammatory drugs. Am J Med 1986; 80: 62.
Mort JR, Aparasu RR, Baer RK. Interaction between selective serotonin reaptake inhibitors and nonsteroidal antuinflammatory drug: review of literature. Pharmacotherapy 2006; 26: 1307-1313.
POLECAMY
© 2019 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe